# Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™

> **NCT02207426** · PHASE1 · COMPLETED · sponsor: **Pharmaero ApS** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tobramycin

## Key facts

- **NCT ID:** NCT02207426
- **Lead sponsor:** Pharmaero ApS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-08
- **Final completion:** 2014-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02207426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02207426, "Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02207426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*